Telomir Pharmaceuticals, Inc.
NASDAQ: TELO
$1.23
+0.02
(+1.65%)
as on
Telomir Pharmaceuticals, Inc. Stock Performance
as on September 26, 2026 at 2:16 pm IST
Day's Low
$1.20$1.23
2.44%
Downside
52 Week's Low
52 Week's High
$0.89$2.0927.76%
Downside
70.00%
Upside
Telomir Pharmaceuticals, Inc. share price movements today
- Previous Close
- $1.21
- Open
- $1.22
- Volume
- 564.9K
- Market Cap
- $83.2M
- Day's Low - High
- $1.20 - $1.23
- 52 Week Low - High
- $0.89 - $2.09
Telomir Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 5.13 %
- 3 Month Return
- -0.81 %
- 1 Year Return
- -11.51 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Telomir Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Telomir Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$83.2M
EPS (TTM)
-1.514
Dividend Yield
0.00%
PE Ratio (TTM)
-0.8
Industry PE ratio
-2.65
PEG Ratio
0.001274578943130031
Return On Equity TTM
-102.69%
Telomir Pharmaceuticals, Inc. Stock Valuation
Track how Telomir Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Telomir Pharmaceuticals, Inc. in the last 5 years
Lowest (-1500.52x)
December 31, 2021
Today (-4.03x)
December 31, 2025
Industry (-2.65x)
December 31, 2025
Highest (-4.03x)
December 31, 2025
Today’s Price to Earnings Ratio: -4.03x
Telomir Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Telomir Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $83.2M | NA | -0.8 | 0.00% | 0.00% | |
| Neutral | $77.8B | -53.76% | -24.41 | -12.57% | 0.00% | |
| StrongBuy | $132.4B | 186.58% | 30.16 | 86.04% | 0.00% | |
| Buy | $82.8B | 23.34% | 19.01 | 84.86% | 0.46% |
Stock Returns calculator for Telomir Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Telomir Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Telomir Pharmaceuticals, Inc. investment value today
Current value as on today
₹95,617
Returns
Returns from Telomir Pharmaceuticals, Inc. Stock
Dollar Impact
₹7,128 (+7.13%)
Indian Investors' Interest in Telomir Pharmaceuticals, Inc. Stock
Search interest for Telomir Pharmaceuticals, Inc. Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Telomir Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Telomir Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Telomir Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Telomir Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Telomir Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 17 September
Thu, 06:28 PM
-Telomir Pharmaceuticals reports preclinical data showing Telomir-Zn restores visual function in age-related macular degeneration model.
Insights on Telomir Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, TELO stock has moved up by 3.4%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 723.6%
About Telomir Pharmaceuticals, Inc.
| Organisation | Telomir Pharmaceuticals, Inc. |
| Headquarters | 100 SE 2nd Street, Miami, FL, 33131, US |
| Industry | Biotechnology |
| CEO | Erez Aminov |
| E-voting on shares | Click here to vote |
Key Management of Telomir Pharmaceuticals, Inc.
Name | Title |
|---|---|
Mr. Erez Aminov | Chairman of the Board & CEO |
Mr. Andriy Mushak CPA | Chief Financial Officer |
Dr. Itzchak Angel Ph.D. | Chief Scientific Advisor |
FAQs
What is Telomir Pharmaceuticals, Inc. share price today?
Telomir Pharmaceuticals, Inc. share price today is $1.23 as on at the close of the market. Telomir Pharmaceuticals, Inc. share today touched a day high of $1.23 and a low of $1.20.
What is the 52 week high and 52 week low for Telomir Pharmaceuticals, Inc. share?
Telomir Pharmaceuticals, Inc. share touched a 52 week high of $2.09 on and a 52 week low of $0.89 on . Telomir Pharmaceuticals, Inc. stock price today i.e. is closed at $1.23,which is 41.18% down from its 52 week high and 38.44% up from its 52 week low.
What is Telomir Pharmaceuticals, Inc.'s market capitalisation today?
Telomir Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
How to invest in Telomir Pharmaceuticals, Inc. Stock (TELO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Telomir Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telomir Pharmaceuticals, Inc. Shares that will get you 1.2195 shares as per Telomir Pharmaceuticals, Inc. share price of $1.23 per share as on September 26, 2026 at 8:46 am IST.
What is the minimum amount required to buy Telomir Pharmaceuticals, Inc. Stock (TELO) from India?
Indian investors can start investing in Telomir Pharmaceuticals, Inc. (TELO) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Telomir Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Telomir Pharmaceuticals, Inc. share’s latest price of $1.23 as on September 26, 2026 at 8:46 am IST, you will get 8.1301 shares of Telomir Pharmaceuticals, Inc.. Learn more about
fractional shares .